Literature DB >> 26900238

Interpretation of ER and Her2neu hormonal receptor in breast cancer.

Tanushri Mukherjee1.   

Abstract

Entities:  

Year:  2015        PMID： 26900238      PMCID： PMC4723685          DOI： 10.1016/j.mjafi.2015.11.007

Source DB:  PubMed          Journal:  Med J Armed Forces India        ISSN： 0377-1237


× No keyword cloud information.
  3 in total

Review 1.  Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

Authors:  D C Allred; J M Harvey; M Berardo; G M Clark
Journal:  Mod Pathol       Date:  1998-02       Impact factor: 7.842

2.  American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer.

Authors:  Antonio C Wolff; M Elizabeth H Hammond; Jared N Schwartz; Karen L Hagerty; D Craig Allred; Richard J Cote; Mitchell Dowsett; Patrick L Fitzgibbons; Wedad M Hanna; Amy Langer; Lisa M McShane; Soonmyung Paik; Mark D Pegram; Edith A Perez; Michael F Press; Anthony Rhodes; Catharine Sturgeon; Sheila E Taube; Raymond Tubbs; Gail H Vance; Marc van de Vijver; Thomas M Wheeler; Daniel F Hayes
Journal:  J Clin Oncol       Date:  2006-12-11       Impact factor: 44.544

3.  Prevalence of molecular subtypes of invasive breast cancer: A retrospective study.

Authors:  Nikhilesh Kumar; Preeti Patni; A Agarwal; M A Khan; Nidhi Parashar
Journal:  Med J Armed Forces India       Date:  2015-06-17
  3 in total
  3 in total

1.  Association of lipid profile biomarkers with breast cancer by molecular subtype: analysis of the MEND study.

Authors:  Anjali Gupta; Veeral Saraiya; April Deveaux; Taofik Oyekunle; Klarissa D Jackson; Omolola Salako; Adetola Daramola; Allison Hall; Olusegun Alatise; Gabriel Ogun; Adewale Adeniyi; Omobolaji Ayandipo; Thomas Olajide; Olalekan Olasehinde; Olukayode Arowolo; Adewale Adisa; Oludolapo Afuwape; Aralola Olusanya; Aderemi Adegoke; Trygve O Tollefsbol; Donna Arnett; Michael J Muehlbauer; Christopher B Newgard; Tomi Akinyemiju
Journal:  Sci Rep       Date:  2022-06-23       Impact factor: 4.996

2.  Association of high-sensitivity C-reactive protein and odds of breast cancer by molecular subtype: analysis of the MEND study.

Authors:  Anjali Gupta; Taofik Oyekunle; Omolola Salako; Adetola Daramola; Olusegun Alatise; Gabriel Ogun; Adewale Adeniyi; April Deveaux; Veeral Saraiya; Allison Hall; Omobolaji Ayandipo; Thomas Olajide; Olalekan Olasehinde; Olukayode Arowolo; Adewale Adisa; Oludolapo Afuwape; Aralola Olusanya; Aderemi Adegoke; Trygve O Tollefsbol; Donna Arnett; Michael J Muehlbauer; Christopher B Newgard; Tomi Akinyemiju
Journal:  Oncotarget       Date:  2021-06-22

3.  Association of body composition with odds of breast cancer by molecular subtype: analysis of the Mechanisms for Established and Novel Risk Factors for Breast Cancer in Nigerian Women (MEND) study.

Authors:  Tomi Akinyemiju; Kelley Jones; Anjali Gupta; Taofik Oyekunle; Veeral Saraiya; April Deveaux; Omolola Salako; Allison Hall; Olusegun Alatise; Gabriel Ogun; Adewale Adeniyi; Omobolaji Ayandipo; Thomas Olajide; Olalekan Olasehinde; Olukayode Arowolo; Adewale Adisa; Oludolapo Afuwape; Aralola Olusanya; Aderemi Adegoke; Trygve O Tollefsbol; Donna Arnett; Adetola Daramola
Journal:  BMC Cancer       Date:  2021-09-25       Impact factor: 4.430
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.